Search research articles
Contact Us
Filters
Showing results (171-180 of 187) with videos related to
Page
of 19
Sort By:
British Journal of Haematology
|
December 23, 2025
The PINNACLE study: A multicentre phase II trial of nilotinib in combination with pegylated interferon-α2b in newly diagnosed chronic phase chronic myeloid leukaemia
David T Yeung, Andrew P Grigg, John Reynolds, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
September 18, 2013
Role of complement activation in obliterative bronchiolitis post-lung transplantation
Hidemi Suzuki, Mark E Lasbury, Lin Fan, et al.
Blood
|
September 5, 2008
Impact of early dose intensity on cytogenetic and molecular responses in chronic- phase CML patients receiving 600 mg/day of imatinib as initial therapy
Timothy P Hughes, Susan Branford, Deborah L White, et al.
JCO Precision Oncology
|
February 9, 2022
Delivering Precision Oncology in a Community Cancer Program: Results From a Prospective Observational Study
Steven F Powell, Elie G Dib, Jonathan S Bleeker, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation
|
June 15, 2012
A panel of lung injury biomarkers enhances the definition of primary graft dysfunction (PGD) after lung transplantation
Rupal J Shah, Scarlett L Bellamy, A Russell Localio, et al.
Leukemia
|
April 23, 2022
Integrated clinical and genomic evaluation of guadecitabine (SGI-110) in peripheral T-cell lymphoma
Jonathan Wong, Emily Gruber, Belinda Maher, et al.
Transplantation
|
October 1, 2025
Characterization of Spirometric Response to Standard-of-care Treatment in Lung Allograft Recipients With Bronchiolitis Obliterans and the Utility of Spirometric Criteria for Rescue Therapy: Implications for the Design of Risk-stratified Clinical Trials
Derek E Byers, Ramsey Hachem, Chadi A Hage, et al.
Transplantation Direct
|
September 24, 2025
Identification of Surrogate Outcome Biomarkers in Lung Allograft Recipients With Bronchiolitis Obliterans: Implications for Randomized Controlled Trials
Derek E Byers, Ramsey Hachem, Chadi A Hage, et al.
Rheumatology Advances in Practice
|
July 15, 2024
The prescription and monitoring of conventional synthetic disease-modifying anti-rheumatic drugs: British Society for Rheumatology guideline scope
Louise Mercer, Abhishek Abhishek, Akhila Kavirayani, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association
|
April 18, 2024
International consensus on the management of metastatic gastric cancer: step by step in the foggy landscape : Bertinoro Workshop, November 2022
Paolo Morgagni, Maria Bencivenga, Fatima Carneiro, et al.
Page
of 19
Search research articles
Search
Showing results (171-180 of 187) with videos related to
Sort By:
Page
of 19
British Journal of Haematology
|
December 23, 2025
The PINNACLE study: A multicentre phase II trial of nilotinib in combination with pegylated interferon-α2b in newly diagnosed chronic phase chronic myeloid leukaemia
David T Yeung, Andrew P Grigg, John Reynolds, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
September 18, 2013
Role of complement activation in obliterative bronchiolitis post-lung transplantation
Hidemi Suzuki, Mark E Lasbury, Lin Fan, et al.
Blood
|
September 5, 2008
Impact of early dose intensity on cytogenetic and molecular responses in chronic- phase CML patients receiving 600 mg/day of imatinib as initial therapy
Timothy P Hughes, Susan Branford, Deborah L White, et al.
JCO Precision Oncology
|
February 9, 2022
Delivering Precision Oncology in a Community Cancer Program: Results From a Prospective Observational Study
Steven F Powell, Elie G Dib, Jonathan S Bleeker, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation
|
June 15, 2012
A panel of lung injury biomarkers enhances the definition of primary graft dysfunction (PGD) after lung transplantation
Rupal J Shah, Scarlett L Bellamy, A Russell Localio, et al.
Leukemia
|
April 23, 2022
Integrated clinical and genomic evaluation of guadecitabine (SGI-110) in peripheral T-cell lymphoma
Jonathan Wong, Emily Gruber, Belinda Maher, et al.
Transplantation
|
October 1, 2025
Characterization of Spirometric Response to Standard-of-care Treatment in Lung Allograft Recipients With Bronchiolitis Obliterans and the Utility of Spirometric Criteria for Rescue Therapy: Implications for the Design of Risk-stratified Clinical Trials
Derek E Byers, Ramsey Hachem, Chadi A Hage, et al.
Transplantation Direct
|
September 24, 2025
Identification of Surrogate Outcome Biomarkers in Lung Allograft Recipients With Bronchiolitis Obliterans: Implications for Randomized Controlled Trials
Derek E Byers, Ramsey Hachem, Chadi A Hage, et al.
Rheumatology Advances in Practice
|
July 15, 2024
The prescription and monitoring of conventional synthetic disease-modifying anti-rheumatic drugs: British Society for Rheumatology guideline scope
Louise Mercer, Abhishek Abhishek, Akhila Kavirayani, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association
|
April 18, 2024
International consensus on the management of metastatic gastric cancer: step by step in the foggy landscape : Bertinoro Workshop, November 2022
Paolo Morgagni, Maria Bencivenga, Fatima Carneiro, et al.
Page
of 19